If you'd like to claim this company profile for Basilard BioTech, please
Contact Us.
Basilard BioTech: Partnerships and Licensing
Partnership and licensing opportunities from Basilard BioTech.
Partnership Title: Our Deterministic Mechanoporation (DMP) gene delivery technology platform – which we call Celletto™
Partnership Description ...
DMP uses fluid flow to drag each cell in suspension onto its own dedicated nanoscale needle, causing poration of both the plasma and nuclear membrane in the process. The cells are then pushed off the needles by reversing flow, after which gene delivery occurs by diffusion of the payload through the single transient pore produced in each cell.
-
High delivery efficiency AND high cellular viability
-
Direct intranuclear delivery
-
Uniform treatment of all cells in the population.
Partnership Types ...
- Licencing Out
We offer our products to other
companies on an 'out-licensing' basis.
- Research and Development
We offer co-development
opportunities.
Partnership Category Areas ...
- Biopharmaceuticals
- Biopharmaceuticals-Gene Delivery
- Biopharmaceuticals-Technology
Partnership Therapy Areas ...
- Antineoplastic and Immunomodulating Agents
- Immuno-oncology
Claim This Profile
This is the Partnership and Licensing section of the company profile page for
Basilard BioTech on the
Pharmaceutical Services
Directory. Companies listed on the directory can update their business information free of charge. If
this is your company and you'd like to claim this profile, please
Contact Us.
Basilard BioTech company details, activities,
contacts and reviews.
Basilard BioTech documents, images and videos.
Basilard BioTech partnership and licensing
opportunities.
Basilard BioTech latest news, announcements and
press releases.
Basilard BioTech global factories, offices and
locations.
Basilard BioTech legal and financial information.
Basilard BioTech blogs, articles and journal
posts.
